Table 1.
Classification of illness severity | Median (IQR*) duration of SARS-CoV-2 positivity in cohort, days | Viral dynamics in patients with severe illness vs those with non-severe illness | p value | |
---|---|---|---|---|
Chen et al (2020)25 | ICU vs non-ICU patients | 11 (95% CI 10–12) | Median time to viral clearance significantly longer in ICU vs non-ICU patients (HR 3·17, 95% CI 2·29–4·37) | Only HR provided |
Chen et al (2020)26 | China CDC guideline (version 7) | 12 (8–16) | Shedding duration varies by severity: asymptomatic 6 days; mild 10 days; moderate 12 days; serious 14 days; critical 32 days | <0·0001 |
Tan et al (2020)17 | China CDC guideline (version 6) | Nasopharyngeal swab: 12 (range 3–38); any sample: 22 (range 3–38) | Viral shedding significantly longer in patients with severe illness: any sample 23 days vs 20 days (note that nasopharyngeal swab 14 vs 11 days was non-significant) | 0·023 (any sample) |
Xu et al (2020)36 | WHO criteria | 17 (13–32) | Higher proportion of patients with severe illness had shedding >15 days (34·2% vs 16·2%) | 0·049 |
Yan et al (2020)37 | China CDC guideline (version 6) | 23 (18–32) | No difference in shedding duration (general illness 23 days vs severe illness 26 days vs critical illness 28 days) | 0·51 |
Zheng et al (2020)23 | China CDC guideline (version 6) | Respiratory sample: 18 (13–29) | Shedding duration significantly longer in patients with severe illness (21 vs 14 days) in respiratory samples; no difference in shedding duration in stool or serum samples | 0·04 |
CDC=Center for Disease Control and Prevention. HR=hazard ratio. ICU=intensive care unit. SARS-CoV-2=severe acute respiratory syndrome coronavirus 2.
IQR unless otherwise stated.